Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q1 FY26 results · Apr–Jun 2025
Divi's Laboratories reported revenue from operations of ₹2,410.00 crore (up 13.8% from Q1 FY25) and net profit of ₹545.00 crore (up 26.7% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,410.00 | 2,118.00 | +13.8% | 2,585.00 | −6.8% |
| Other income | 119.00 | 79.00 | +50.6% | 86.00 | +38.4% |
| Total income | 2,529.00 | 2,197.00 | +15.1% | 2,671.00 | −5.3% |
| Profit before tax | 733.00 | 604.00 | +21.4% | 864.00 | −15.2% |
| Net profit for the period | 545.00 | 430.00 | +26.7% | 662.00 | −17.7% |
| EPS, basic (₹) | 20.49 | 16.20 | +26.5% | 24.93 | −17.8% |
| Net margin (%) | 22.6 | 20.3 | 25.6 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,357.00 | 2,063.00 | +14.3% | 2,536.00 | −7.1% |
| Other income | 119.00 | 79.00 | +50.6% | 87.00 | +36.8% |
| Total income | 2,476.00 | 2,142.00 | +15.6% | 2,623.00 | −5.6% |
| Profit before tax | 747.00 | 603.00 | +23.9% | 861.00 | −13.2% |
| Net profit for the period | 557.00 | 430.00 | +29.5% | 667.00 | −16.5% |
| EPS, basic (₹) | 20.95 | 16.18 | +29.5% | 25.12 | −16.6% |
| Net margin (%) | 23.6 | 20.8 | 26.3 |
Consolidated
- Filed with BSE
- 06 Aug 2025, 12:50 IST
- Board meeting
- 06 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Aug 2025, 12:50 IST
- Board meeting
- 06 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE